News & Analysis on Clinical Trial Services & Contract Research And Development
The European Commission has given Europe a boost in the field of structural genomics, awarding the European Molecular Biology Laboratory (EMBL) and its partners €10 million to create a common platform for researchers working in the field of biological...
DSM will cut around 500 jobs at its Chemelot site in Geleen, the Netherlands over the next two years, in an effort to cut costs by over €50 million per annum. The jobs will largely go in support services and manufacturing staff departments.
In its last set of annual results before being acquired by General Electric, Amersham of the UK reported lower profits last year as currency effects bit into the company's bottom line, but saw its drug discovery unit move into the black ahead of...
Newly formed UK company Structure Vision has launched a software package designed to analyse the behaviour of particulate material - including powders and tablets - in enclosed spaces.
Asthma is now one of the world's most common long-term conditions, according to figures released today during the World Asthma Meeting in Bangkok, Thailand, and the UK has the highest rate in the world.
Niche Phase I/IIa clinical development specialist Pharmaceutical Profiles says it has seen a surge in demand for its development services in the Japanese market - with particular interest being shown in its new human microdosing service.
Introgen Therapeutics has been awarded a US patent on a way to store adenoviruses so that they remain viable for over a year.